default author photo

Thomas U. Marron

Mount Sinai Health System - Precision Immunology Institute

United States

SCHOLARLY PAPERS

2

DOWNLOADS

179

TOTAL CITATIONS

2

Scholarly Papers (2)

1.

TREM2 Sensing of Tumor Cell Efferocytosis Promotes a Macrophage Molecular State that Limits NK Cell Antitumor Immunity

Number of pages: 48 Posted: 05 Aug 2021
Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Human Immune Monitoring Center, Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute, Icahn School of Medicine at Mount SinaiMount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute, Icahn School of Medicine at Mount SinaiMount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Precision Immunology Institute and Mount Sinai Health System - Department of Medicine, Hematology and Medical Oncology
Downloads 108 (649,907)
Citation 2

Abstract:

Loading...

2.

Reproducible Safety and Efficacy of Atezolizumab Plus Bevacizumab for HCC in Clinical Practice: Results of the AB-Real Study

Number of pages: 19 Posted: 09 Jul 2022
Imperial College London - Hammersmith Hospital, CHA University - CHA Bundang Medical Center, Imperial College London - Hammersmith Hospital, Kindai University, Mount Sinai Health System - Division of Hematology/ Oncology, Mount Sinai Health System - Precision Immunology Institute, Mount Sinai Health System - Division of Hematology/ Oncology, University of Kansas - Cancer Center, University of Kansas - Cancer Center, IRCCS Humanitas Research Hospital, IRCCS Humanitas Research Hospital, IRCCS Humanitas Research Hospital, University of Vienna, University of Vienna, Medical University of Vienna - Vienna Hepatic Hemodynamic Laboratory, Royal Marsden NHS Foundation Trust, National Yang Ming University - Taipei Veterans General Hospital, University of Texas at Dallas - Southwestern Medical Center, University of Oklahoma - Stephenson Cancer Center, University of Pisa, University of Pisa, University of Pisa, University of Freiburg - Faculty of Medicine, Hannover Medical School - Department of Gastroenterology, Hepatology and Endocrinology, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, University of Hamburg - University Medical Center Hamburg-Eppendorf, University Medical Center Mainz, Kindai University - Department of Gastroenterology and Hepatology, IRCCS Humanitas Research Hospital, University of Texas at Dallas - Division of Digestive and Liver Diseases, Imperial College London, Imperial College London - Hammersmith Hospital, Roche, CHA University - CHA Bundang Medical Center and Imperial College London
Downloads 71 (867,774)

Abstract:

Loading...

Advanced HCC, systemic treatment, first line, atezolizumab, bevacizumab